Rates were higher among patients with lower (8–10 g/dL) versus higher (>10 g/dL) baseline Hb, with the exception of stroke, for which rates were higher for patients initiating ESA at higher versus lower Hb (12 vs 7.1 per 100 patient-years). The gene discussed is GSTM1; the disease is stroke disorder.